Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Attend this 48-minute webinar presented by Dr. Omar Farah from Thermo Fisher to explore strategies for optimizing induced pluripotent stem cell (iPSC)-derived cell therapy development for allogeneic and therapeutic applications. Learn to tackle key challenges in iPSC culture scalability, differentiation protocols, and production workflow optimization that are crucial for cell therapy developers. Discover practical solutions for addressing bottlenecks in iPSC-derived cell therapy development through a detailed case study using iPSC-derived CAR-NK (iNK) cells as an example. Master successful iPSC culturing and scale-up techniques before diving into an optimized multi-step protocol for differentiating iPSCs to hematopoietic stem and progenitor cells (HSPCs) and subsequently to natural killer (NK) cells. Gain insights from Dr. Farah's extensive background in embryo lineage specification, stem cell-based models, and regenerative medicine applications. Earn 1 PACE credit upon completion by registering as a Labroots member and following the provided certification process, with credits valid until October 15, 2026.
